Jeanette H W Leusen Selected Research

Jeanette H W Leusen Research Topics

Disease

43	Neoplasms (Cancer) 04/2024 - 03/2006
8	Infections 07/2023 - 01/2015
6	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 01/2012
5	Inflammation (Inflammations) 07/2023 - 01/2015
4	Respiratory Syncytial Virus Infections 01/2020 - 01/2014
3	Lymphoma (Lymphomas) 10/2021 - 08/2014
3	Melanoma (Melanoma, Malignant) 01/2015 - 02/2006
3	Neoplasm Metastasis (Metastasis) 01/2015 - 02/2006
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2022
2	Anaphylaxis (Anaphylactic Shock) 10/2022 - 01/2011
2	Multiple Myeloma 01/2022 - 01/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 02/2009 - 06/2006
2	Pneumococcal Infections 06/2003 - 06/2003
1	Communicable Diseases (Infectious Diseases) 09/2023
1	Hematologic Neoplasms (Hematological Malignancy) 07/2023
1	Neuroblastoma 01/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Ischemia 01/2021
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2021
1	Hypersensitivity (Allergy) 01/2018
1	Confusion (Bewilderment) 01/2016
1	Immune System Diseases (Immune Disorders) 11/2015
1	Polyneuropathies (Polyneuropathy) 08/2014
1	Paraproteinemias (Monoclonal Gammopathy) 08/2014
1	Food Hypersensitivity (Food Allergy) 10/2013
1	Unstable Angina 11/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2010
1	Coronary Disease (Coronary Heart Disease) 08/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2009
1	Acute Coronary Syndrome 08/2009

Drug/Important Bio-Agent (IBA)

28	AntibodiesIBA 04/2024 - 08/2006
21	Immunoglobulin G (IgG)IBA 01/2023 - 06/2003
18	Immunoglobulin A (IgA)IBA 09/2023 - 03/2006
10	Monoclonal AntibodiesIBA 01/2020 - 02/2009
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2009
8	Complement System Proteins (Complement)IBA 10/2022 - 06/2003
7	CytokinesIBA 07/2023 - 02/2006
6	Fc Receptors (Fc Receptor)IBA 01/2019 - 04/2010
4	LigandsIBA 06/2023 - 01/2019
4	AntigensIBA 10/2022 - 06/2006
4	IgG Receptors (Fc gamma RI)IBA 10/2022 - 02/2006
4	Antigen-Antibody Complex (Immune Complex)IBA 10/2022 - 12/2010
4	ErbB Receptors (EGF Receptor)IBA 08/2021 - 04/2010
4	Rituximab (Mabthera)FDA Link 01/2019 - 12/2010
3	AllergensIBA 10/2022 - 10/2013
3	glutaminyl-peptide cyclotransferaseIBA 01/2022 - 01/2019
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 02/2006
3	Cetuximab (Erbitux)FDA Link 01/2019 - 12/2010
3	Glycoproteins (Glycoprotein)IBA 08/2014 - 08/2006
3	Fc gamma receptor IIAIBA 11/2012 - 07/2005
2	Fc(alpha) receptorIBA 09/2023 - 01/2023
2	Sialic AcidsIBA 06/2023 - 01/2023
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 06/2023 - 01/2023
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2023 - 01/2015
2	daratumumabIBA 01/2022 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
2	Palivizumab FDA Link 01/2020 - 01/2018
2	CD20 AntigensIBA 01/2014 - 01/2012
2	Complement Receptors (Complement Receptor)IBA 10/2013 - 12/2011
2	ofatumumab FDA Link 12/2011 - 12/2010
1	Bispecific AntibodiesIBA 04/2024
1	CollagenIBA 01/2024
1	TransferasesIBA 01/2023
1	dinutuximabIBA 01/2023
1	SialyltransferasesIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	CaspasesIBA 10/2021
1	IgA receptor (protein B)IBA 10/2021
1	IntegrinsIBA 08/2021
1	Glutamic Acid (Glutamate)FDA Link 08/2021
1	LectinsIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	B7-H1 AntigenIBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	necitumumabIBA 01/2019
1	motavizumab (Numax)IBA 01/2018
1	InterferonsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 12/2015
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2015
1	SugarsIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	Immunoglobulin M (IgM)IBA 08/2014
1	src-Family KinasesIBA 01/2014
1	Immunoglobulin E (IgE)IBA 10/2013
1	Platelet Activating FactorIBA 01/2011

Therapy/Procedure

18	Therapeutics 04/2024 - 02/2006
16	Immunotherapy 12/2023 - 06/2006
1	Intranasal Administration 01/2020
1	Intravenous Injections 01/2015